IMARC Group, a leading market research company, has recently releases report titled “Nuclear Medicine Equipment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” The study provides a detailed analysis of the industry, including the global nuclear medicine equipment market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Report Highlights
How big is the nuclear medicine equipment market?
The global nuclear medicine equipment market size reached US$ 2.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.3 Billion by 2028, exhibiting a growth rate (CAGR) of 6.65% during 2023-2028.
What is nuclear medicine equipment?
Nuclear medicine equipment is a medical device, which is utilized extensively in the healthcare industry for treating and diagnosing several diseases, such as cancer, and cardiovascular and neurological disorders, by generating anatomical images. These devices are further used for developing drugs and examining various processes of tissue blood flow, cell receptor expression, neurotransmitter activity, abnormal cell and metabolism of the patient.
Request for a free sample copy of this report: https://www.imarcgroup.com/nuclear-medicine-equipment-market/requestsample
What are the growth prospects and trends in the nuclear medicine equipment industry?
The increasing requirement for personalized medicines in the healthcare sector and the rising prevalence of chronic diseases amongst the geriatric population are primarily driving the nuclear medicine equipment market. Moreover, the widespread adoption of various technologically advanced systems, such as radiotracers and imaging systems and significant investments in research and development (RD) activities in the field of biotechnology are propelling the market growth. Other factors, such as overall improvement in the medical infrastructure and the rising utilization of position emission tomography (PET) and single-photon emission computed tomography (SPECT) for capturing accurate nuclear medicine imaging, are creating a positive outlook in the market across the globe.
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by Product:
- Single-Photon Emission Computed Tomography
- Standalone
- Hybrid
- Positron Emission Tomography
- Standalone
- Hybrid
- Planar Scintigraphy
Breakup by Application:
- Neurology
- Oncology
- Cardiology
- Others
Breakup by End User:
- Hospitals
- Imaging Centers
- Academic and Research Institutes
- Others
Breakup by Region:
- North America (U.S. Canada)
- Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
- Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
- Latin America (Brazil, Mexico)
- Middle East Africa
Who are the key players operating in the industry?
The report covers the major market players including:
- Biodex Medical Systems Inc. (Mirion Technologies Inc.)
- Cardinal Health Inc.
- CMR Naviscan Corporation
- DDD-Diagnostic A/S
- Digirad Corporation
- General Electric Company
- Koninklijke Philips N.V.
- Mediso Ltd.
- Neusoft Corporation
- Siemens AG
- SurgicEye GmbH
- Toshiba Corporation.
Ask Analyst for Customization and Browse full report with TOC List of Figure: https://www.imarcgroup.com/request?type=report&id=4598&flag=C
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/
